Impact of taxanes in association with anthracyclines in 1st line chemotherapy for metastatic breast cancer (MBC):: Comprehensive review of 2805 patients in 7 phase III trials.

被引：0
|
作者：
Bria, E [1 ]
Nistico, C [1 ]
Cuppone, F [1 ]
Giannarelli, D [1 ]
Terzoli, E [1 ]
机构：
[1] Regina Elena Inst Canc Res, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
659
引用
收藏
页码：41S / 41S
页数：1
相关论文
共 50 条
  • [1] Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma -: Pooled analysis of 2805 patients
    Bria, E
    Giannarelli, D
    Felici, A
    Peters, WP
    Nisticò, C
    Vanni, B
    Cuppone, F
    Cognetti, F
    Terzoli, E
    [J]. CANCER, 2005, 103 (04) : 672 - 679
  • [2] A PHASE 2 STUDY OF OXALIPLATIN (O)-CAPECITABINE (C) CHEMOTHERAPY IN METASTATIC BREAST CANCER (MBC) PATIENTS PRETREATED WITH ANTHRACYCLINES AND TAXANES
    Valerio, MariaRosaria
    Rinaldi, Gaetana
    Badalamenti, Giuseppe
    Arcara, Carlo
    Cicero, Giuseppe
    Sortino, Cettina
    Spinnato, Francesca
    Maiorana, Oriana
    Cocchiara, Anna
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 20 - 20
  • [3] A phase 2 study of oxaliplatin (O) - capecitabine (C) chemotherapy in metastatic breast cancer (MBC) patients pretreated with anthracyclines and taxanes.
    Gebbia, N
    Fulfaro, F
    Badalamenti, G
    Arcara, C
    Cicero, G
    Rinaldi, G
    Vizzini, L
    Spinnato, F
    Russo, A
    Valerio, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [4] Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Anton, A
    Puertolas, T
    Ramos, M
    Barnadas, A
    Florian, J
    Grande, R
    Ribelles, N
    Lomas, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 64S - 64S
  • [5] MULTICENTER, PHASE II STUDY OF LAROTAXEL IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC) PROGRESSING AFTER ANTHRACYCLINES, TAXANES AND CAPECITABINE
    Ozguroglu, M.
    Mansutti, M.
    Kerr, R.
    Awada, A.
    Rha, S. Y.
    Im, Y. H.
    Perez Manga, G.
    Germann, N.
    Fumoleau, P.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 69 - 69
  • [6] A PHASE II STUY OF OXALIPLATIN (O) - CAPECITABINE (C) CHEMOTHERAPY IN METSTATIC BREAST CANCER (MBC) PATIENTS PRETREATED WITH ANTHRACYCLINES AND TAXANES
    Valerio, Maria Rosaria
    Lo Mauro, M.
    Signorelli, C.
    Scibilia, C.
    Adile, C.
    Macaluso, S.
    Sortino, G.
    Cuttone, F.
    Lo Grasso, Geraldine
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [7] Phase III study of ixabepilone plus capecitabine in patients with metastatic breast cancer (MBC) progressing after anthracyclines and taxanes:: subgroup analysis of patients receiving ixabepilone in the first-line setting
    Jassem, J.
    Thomas, E.
    Gomez, H.
    Li, R. K.
    Chung, H. C.
    Fein, L. E.
    Chan, V. F.
    Peck, R. A.
    Mukhopadhyay, P.
    Roche, H.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 213 - 214
  • [8] New aromatase inhibitors (Als) as 2nd-line endocrine therapy (ET) in metastatic breast cancer (MBC):: A comprehensive review of 5832 women from 14 phase III trials.
    Carlini, P
    Bria, E
    Giannarelli, D
    Ferretti, G
    Papaldo, P
    Fabi, A
    Ruggeri, E
    Milella, M
    Terzoli, E
    Cognetti, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 34S - 34S
  • [9] Capecitabine and trastuzumab: a phase II study in HER2-overexpressing metastatic breast cancer (MBC) patients pretreated with anthracyclines and/or taxanes
    Schaller, G
    Bangemann, N
    Gonsch, T
    Weber, J
    Kleine-Tebbe, A
    Conrad, B
    Klare, P
    Hindenburg, HJ
    Ruhmland, B
    Lakner, V
    Hinke, A
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S94 - S95
  • [10] Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Jones, Alison
    O'Brien, Mary
    Sommer, Harald
    Nowara, Elzbieta
    Welt, Anja
    Pienkowski, Tadeusz
    Rolski, Janusz
    Pham, My-Linh
    Perraud, Kevin
    Trillet-Lenoir, Veronique
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 755 - 763
12345